Eyenovia

www.eyenovialab.com
295 Madison Ave, Suite 2400
New York, NY 10017

Company Info

Phone
(917) 289-1117

Year Established
2014

Ticker
EYEN

Exchange
NASDAQ

Contacts

Michael Rowe
CEO

John Gandolfo
CFO

Sean Ianchulev
Chair

Bren Kern
COO

Norbert Lowe
VP, Commercial

Company Description

Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthrough treatments for front and back-of-the-eye diseases, which are made possible by the company's transformative, high precision ophthalmic delivery platform.